Shares of Gilead Sciences, Inc. dropped nearly 2.5% on Wednesday and extended losses after hours following a report that the ...

There were empty seats in San Francisco last week at an annual international science conference which has delivered some of ...

Trump's second term has included pauses to HIV public awareness campaigns and the cancellation of at least 20 grants funding ...

One dose of the Jynneos vaccine was 58% effective against mpox infection overall and 84% in people without HIV, but only 35% ...

A pioneering study at UKZN has demonstrated that 20% of HIV patients in the trial remained off antiretroviral therapy while maintaining viral suppression.

For the majority of people with the virus in the U.S., dying with HIV has turned into living a long life with HIV.

HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.

In his first term, President Donald Trump launched a bold and successful initiative against HIV. This time around, the ...

I think what I've really wanted to do since I was a teenager was work on HIV and TB, and conditions that affected people who ...

Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...

During medical school, I came across a professor who introduced me to research—up until that point, I was content with being ...

Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center, collaborates with researchers from the Kenya Medical Research Institute ...